Oklahoma Law Injury Blog

Once the World’s Top-Selling Anti-Diabetes Medication, Avandia Still Receives Harsh Blows.

Savannah Dunn on September 24, 2010

The European Medicines Agency (EMA), recommended suspension of marketing authorizations for anti-diabetes medicines containing rosiglitazone. These medicines, including Avandia, will stop being available in Europe within the next few months. Continue reading

© 2019 McIntyre Law, P.C. All Rights Reserved